(Q38016810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674563%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Peptide targeted lipid nanoparticles for anticancer drug delivery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674563%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674563%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Efrosini Kokkoli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674563%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Timothy R Pearce

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674563%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

language of work or name

English

0 references

publication date

5 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674563%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674563%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674563%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674563%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

3803-22, 3710

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22674563%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

cites work

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Targeting kidney mesangium by nanoparticles of defined size

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Renal clearance of quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Endocytic mechanisms for targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Endocytosis of nanomedicines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

More effective nanomedicines through particle design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Cancer chemotherapy with lipid-based nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Nanomedicine in cancer therapy: innovative trends and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Angiogenesis as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Organ targeting in vivo using phage display peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Binding of activated alpha2-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulates PAK-2-dependent activation of LIMK

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

A novel DDS strategy, "dual-targeting", and its application for antineovascular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Anti-neovascular therapy using novel peptides homing to angiogenic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Aminopeptidase A is a functional target in angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Cardiac safety of liposomal anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

G proteins: transducers of receptor-generated signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Hypothalamic hormones and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Somatostatin, cortistatin and their receptors in tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Peptide-labeled supramolecular aggregates as selective doxorubicin carriers for delivery to tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Peptide modified nanocarriers for selective targeting of bombesin receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Targeting properties of peptide-modified radiolabeled liposomal nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Cellular uptake of the tat protein from human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Tat peptide-mediated cellular delivery: back to basics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Pep-1 Peptide-modified liposomal carriers for intracellular delivery of gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Internalization of p53(14-29) peptide amphiphiles and subsequent endosomal disruption results in SJSA-1 cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Targeted therapies in metastatic renal cell carcinoma: overview of the past year

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Recent advances in pathway-targeted cancer drug therapies emerging from cancer genome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Integrins in cancer: biological implications and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Preparation of RGD-modified long circulating liposome loading matrine, and its in vitro anti-cancer effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Solution stability of linear vs. cyclic RGD peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

RGD-targeted paramagnetic liposomes for early detection of tumor: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Design of a novel fibronectin-mimetic peptide-amphiphile for functionalized biomaterials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Cell adhesion molecules in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

pH-Sensitive PEGylated liposomes functionalized with a fibronectin-mimetic peptide show enhanced intracellular delivery to colon cancer cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

PR_b-targeted PEGylated liposomes for prostate cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Binding of the fibronectin-mimetic peptide, PR_b, to alpha5beta1 on pig islet cells increases fibronectin production and facilitates internalization of PR_b functionalized liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

PHSCNK-Modified and doxorubicin-loaded liposomes as a dual targeting system to integrin-overexpressing tumor neovasculature and tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Liposomes modified with YIGSR peptide for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Physico-chemical stability of colloidal lipid particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Epidermal growth factor receptor mutations in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Fibroblast growth factor signalling: from development to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Fibroblast growth factors, their receptors and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Increasing the antitumor efficacy of doxorubicin-loaded liposomes with peptides anchored via a chelator lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

The cell biology of thrombospondin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Review of epidermal growth factor receptor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

ErbB receptors: from oncogenes to targeted cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Lymphangiogenesis in development and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

LyP-1-conjugated doxorubicin-loaded liposomes suppress lymphatic metastasis by inhibiting lymph node metastases and destroying tumor lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Cooperative nanomaterial system to sensitize, target, and treat tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Targeting the neural cell adhesion molecule in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Identification of a neuritogenic ligand of the neural cell adhesion molecule using a combinatorial library of synthetic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Solid lipid nanoparticles as a drug delivery system for peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Lipid-based nanotherapeutics for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Antibody-targeted liposomes in cancer therapy and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Targeted drug delivery to tumors: myths, reality and possibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Strategies in the design of nanoparticles for therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Targeting of drugs and nanoparticles to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Nanoparticle-mediated cellular response is size-dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Sheddable coatings for long-circulating nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Reduction-triggered delivery using nucleoside-lipid based carriers possessing a cleavable PEG coating.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Nanocarriers' entry into the cell: relevance to drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832

Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201200832